Provided by Tiger Trade Technology Pte. Ltd.

Xeris Pharmaceuticals Inc

5.97
+0.03000.51%
Volume:1.40M
Turnover:8.43M
Market Cap:1.03B
PE:1.86K
High:6.12
Open:6.01
Low:5.86
Close:5.94
52wk High:10.08
52wk Low:3.59
Shares:172.43M
Float Shares:159.00M
Volume Ratio:0.46
T/O Rate:0.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0032
EPS(LYR):0.0032
ROE:-617.16%
ROA:4.40%
PB:75.20
PE(LYR):1,861.55

Loading ...

Mar 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 02, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 02, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 02, 2026

Major Issues Report

Form 8-K - Current report
Feb 27, 2026

Major Issues Report

Form 8-K - Current report
Jan 08, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 08, 2026

Major Issues Report

Form 8-K - Current report
Dec 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 01, 2025

Major Issues Report

Form 8-K - Current report
Nov 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Sep 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2025

Major Issues Report

Form 8-K - Current report